Clinical Trial Update: Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage

View source ↗

Summary

This clinical trial update describes an ex vivo approach to minimally invasive hematoma evacuation using a modified tissue plasminogen activator for intracerebr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Modified Tissue Plasminogen Activator (modified tissue plasminogen activator)

Snippet

Sponsor: University Hospital, Lille | Conditions: Intracerebral Hemorrhage, Hemorrhagic Risk Conditions | Status: NOT_YET_RECRUITING